ADVANCED PANCREATIC-CANCER - A PHASE I-II TRIAL OF CISPLATIN, HIGH-DOSE CYTARABINE, AND CAFFEINE

被引:29
作者
DOUGHERTY, JB
KELSEN, D
KEMENY, N
MAGILL, G
BOTET, J
NIEDZWIECKI, D
机构
[1] CORNELL UNIV,MED CTR,MEM SLOAN KETTERING CANC CTR,DEPT MED,NEW YORK,NY 10021
[2] CORNELL UNIV,MED CTR,MEM SLOAN KETTERING CANC CTR,DEPT DIAGNOST RADIOL,NEW YORK,NY 10021
[3] CORNELL UNIV,MED CTR,MEM SLOAN KETTERING CANC CTR,DEPT BIOSTAT,NEW YORK,NY 10021
关键词
D O I
10.1093/jnci/81.22.1735
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:1735 / 1738
页数:4
相关论文
共 31 条
[1]   PHASE-II EVALUATION OF DIHYDROXYANTHRACENEDIONE (DHAD, NSC301739) IN PATIENTS WITH UPPER GASTROINTESTINAL TUMORS - A PRELIMINARY-REPORT [J].
BEDIKIAN, AY ;
STROEHLEIN, J ;
KORINEK, J ;
KARLIN, D ;
VALDIVIESO, M ;
BODEY, GP .
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1983, 6 (04) :473-476
[2]  
BERGERAT JP, 1981, CANCER RES, V41, P25
[3]   MICE, MEN, MUSTARDS AND METHYLATED XANTHINES - THE POTENTIAL ROLE OF CAFFEINE AND RELATED DRUGS IN THE SENSITIZATION OF HUMAN-TUMORS TO ALKYLATING-AGENTS [J].
BYFIELD, JE ;
MURNANE, J ;
WARD, JF ;
CALABROJONES, P ;
LYNCH, M ;
KULHANIAN, F .
BRITISH JOURNAL OF CANCER, 1981, 43 (05) :669-683
[4]   INTEGRATION OF CHEMOTHERAPY INTO A COMBINED MODALITY APPROACH FOR CANCER TREATMENT .4. PANCREATIC ADENOCARCINOMA [J].
CARTER, SK ;
COMIS, RL .
CANCER TREATMENT REVIEWS, 1975, 2 (03) :193-214
[5]  
COHEN MH, 1980, CANCER TREAT REP, V64, P151
[6]   MITOMYCIN-C - REVIEW [J].
CROOKE, ST ;
BRADNER, WT .
CANCER TREATMENT REVIEWS, 1976, 3 (03) :121-139
[7]  
DEVITA VT, 1985, CANCER PRINCIPLES PR
[8]  
DREWINKO B, 1980, CISPLATIN CURRENT ST, P37
[9]  
FRAM RJ, 1987, CANCER RES, V47, P3360
[10]  
HAYES DM, 1977, CANCER, V39, P1372, DOI 10.1002/1097-0142(197704)39:4<1372::AID-CNCR2820390404>3.0.CO